Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 44-48

  Johansson, Anna G ^a   Lindh, Erik ^a   Blum, Werner F ^b   Kollerup, Gina ^c   Sørensen, Ole H ^c   Ljunghall, Sverker ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Osteoporosecentret ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; HUMAN GROWTH HORMONE; OSTEOCALCIN; PROCOLLAGEN; PYRIDINE DERIVATIVE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FLUSHING; HEADACHE; HUMAN; LEG PAIN; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA;

ADULT; BONE DEVELOPMENT; CALCIUM; COLLAGEN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0030049568     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.1.44     Document Type: Article

References (35)

1. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH. 1985 Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism. 34:124-129.
2. Aloia JF, Vaswani A, Meunier PJ, et al. 1987 Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int. 40:253-259.
3. Canalis E. 1994 Editorial: Skeletal growth factors and aging. J Clin Endocrinol Metab. 78:1009-1010.
4. Eriksen EF, Kassem M, Brixen K. 1993 Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res. 40:95-98.
5. Schmid C. 1993 IGFs: function and clinical importance. 2 The regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins. J Intern Med. 234:535-542.
6. 3 and activity on human osteoblast-like cells in short-term cultures. Bone. 11:81-86.
7. Hock JM, Centrella M, Canalis E. 1988 Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 122:254-260.
8. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. 1994 Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res. 9:915-921.
9. Johansson AG, Burman F, Westermark K, Ljunghall S. 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med. 232:447-452.
10. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab. 78:669-674.
11. Bing-You RG, Denis M-C, Rosen CJ. 1993 Low bone mineral density in adults with previous hypothalamic-pituitary tumours: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcif Tissue Int. 52:183-187.
12. Rosén T, Hansson T, Granhed H, Szucs J, Bengtsson B-Å. 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:201-206.
13. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. 1990 A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res. 5:609-618.
14. Vandeweghe M, Taelman P, Kaufman J-M. 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf). 39:409-415.
15. Kotzmann H, Bernecker P, Hübsch P, et al. 1993 Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res. 8:459-465.
16. Diamond T, Nery L, Posen S. 1989 Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med. 111:567-573.
17. Rosén T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson B-Å. 1994 Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab. 1:55-66.
18. Clemmons DR, Van Wyk JJ. 1984 Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab. 13:113-143.
19. Holly JMP, Wass JAH. 1989 Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol. 122:611-618.
20. Ljunghall S, Johansson AG, Burman P, Kämpe O, Lindh E, Karlsson FA. 1992 Low plasma levels of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis. J Intern Med. 232:59-64.
21. Kollerup G, Thamsborg G, Bhatia H, Sørensen OH. 1992 Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest. 52:657-662.
22. Blum WF, Ranke MB, Bierich JR. 1988 A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess of IGF-I. Acta Endocrinol (Copenh). 118:374-380.
23. Blum WF, Ranke MB, Kietzmann K, Cauggel E, Zeisel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
24. Spencer EM, Liu CC, Si ECC, Howard GA. 1991 in vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone. 12: 21-26.
25. Yeh JK, Aloia JF, Chen M. 1994 Growth hormone administration potentiates the effect of treadmill exercise on long bone formation but not on the vertebrae in middle-aged rats. Calcif Tissue Int. 54:38-43.
26. Mueller K, Cortesi R, Modrowski D, Marie PJ. 1994 Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomz/ed rats. Am J Physiol. 267:E1-E6.
27. Rubin CD, Reed B, Sakhaee K, Pak CYC. 1994 Treating a patient with the Werner syndrome and osteoporosis using recombinant human insulin-like growth factor. Ann Intern Med. 121:665-668.
28. Slootweg MC, Most WW, van Beek E, Schot LPC, Papapoulos SE, Löwik CWGM. 1992 Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. J Endocrinol. 132:433-438.
29. Mochizuki H, Hakeda Y, Wakatsuki N, et al. 1992 Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology. 131:1075-1080.
30. Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF. 1994 Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner. 24:81-94.
31. Välimäki MJ, Tähtelä R, Jones JD, Peterson JM, Riggs BL. 1994 Bone resorption in healthy and osteoporotic post menopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links. Eur J Endocrinol. 131:258-262.
32. Johansson AG, Lindh E, Ljunghall S. 1992 Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet. 339:1619.
33. Fleet JC, Bruns ME, Hock JM, Wood RJ. 1994 Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats. Endocrinology. 134:1755-1760.
34. Blum WF, Hall K, Ranke MB, Wilton P. 1993 Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor 1. Acta Pædiatr Suppl. 391:15-19.
35. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL. 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab. 77:1384-1387.